| Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference | 09/11 16:05 | globenewswire.com |
| Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients | 09/04 07:00 | globenewswire.com |
| Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results | 08/14 17:21 | globenewswire.com |
| Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection | 07/29 07:00 | globenewswire.com |
| Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism | 07/02 16:05 | globenewswire.com |
| Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues | 06/17 09:36 | investorplace.com |
| 3 High-Potential Penny Stocks to Turn $1000 into $1 Million: June 2024 | 06/11 15:18 | investorplace.com |
| Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation | 06/03 16:01 | globenewswire.com |
| Eledon Pharmaceuticals (ELDN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now | 05/27 10:56 | zacks.com |
| Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy? | 05/22 13:01 | zacks.com |